Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.

Robertson MJ, Gordon CP, Gilbert J, McCluskey A, Sakoff JA.

Bioorg Med Chem. 2011 Sep 15;19(18):5734-41. doi: 10.1016/j.bmc.2011.01.031. Epub 2011 Feb 1.

PMID:
21855357
2.

Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.

Hill TA, Stewart SG, Ackland SP, Gilbert J, Sauer B, Sakoff JA, McCluskey A.

Bioorg Med Chem. 2007 Sep 15;15(18):6126-34. Epub 2007 Jun 20.

PMID:
17606377
3.

Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.

Hill TA, Stewart SG, Sauer B, Gilbert J, Ackland SP, Sakoff JA, McCluskey A.

Bioorg Med Chem Lett. 2007 Jun 15;17(12):3392-7. Epub 2007 Apr 2.

PMID:
17451951
4.

Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.

Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A.

Bioorg Med Chem Lett. 2004 Apr 19;14(8):1969-73.

PMID:
15050639
5.

Synthesis and anticancer activity of a series of norcantharidin analogues.

Tarleton M, Gilbert J, Sakoff JA, McCluskey A.

Eur J Med Chem. 2012 Aug;54:573-81. doi: 10.1016/j.ejmech.2012.06.010. Epub 2012 Jun 15.

PMID:
22796041
6.

Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.

Tu GG, Zhan JF, Lv QL, Wang JQ, Kuang BH, Li SH.

Med Chem. 2014 Jun;10(4):376-81.

PMID:
23909288
7.

Cytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.

Spare LK, Falsetta P, Gilbert J, Harman DG, Baker MA, Li F, McCluskey A, Clegg JK, Sakoff JA, Aldrich-Wright JR, Gordon CP.

ChemMedChem. 2017 Jan 20;12(2):130-145. doi: 10.1002/cmdc.201600573. Epub 2017 Jan 3.

PMID:
27921386
8.

Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue.

Balan D, Burns CJ, Fisk NG, Hügel H, Huang DC, Segal D, White C, Wagler J, Rizzacasa MA.

Org Biomol Chem. 2012 Oct 28;10(40):8147-53.

PMID:
22964776
9.

Synthesis and cytotoxicity of a salicylihalamide A analogue.

Tang S, Erickson KL.

J Nat Prod. 2008 May;71(5):898-901. doi: 10.1021/np070694q. Epub 2008 Apr 12.

PMID:
18407694
10.

Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.

McCluskey A, Ackland SP, Bowyer MC, Baldwin ML, Garner J, Walkom CC, Sakoff JA.

Bioorg Chem. 2003 Feb;31(1):68-79.

PMID:
12697169
11.

Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.

Hill TA, Stewart SG, Gordon CP, Ackland SP, Gilbert J, Sauer B, Sakoff JA, McCluskey A.

ChemMedChem. 2008 Dec;3(12):1878-92. doi: 10.1002/cmdc.200800192.

PMID:
19025735
12.

Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.

Han HW, Qiu HY, Hu C, Sun WX, Yang RW, Qi JL, Wang XM, Lu GH, Yang YH.

Bioorg Med Chem Lett. 2016 Jul 15;26(14):3237-42. doi: 10.1016/j.bmcl.2016.05.063. Epub 2016 May 24.

PMID:
27262599
13.

Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity.

Wang X, Berger DM, Salaski EJ, Torres N, Dutia M, Hanna C, Hu Y, Levin JI, Powell D, Wojciechowicz D, Collins K, Frommer E, Lucas J.

J Med Chem. 2010 Nov 11;53(21):7874-8. doi: 10.1021/jm1007566.

PMID:
20961062
14.

Synthesis, cytotoxicity and inhibition of NO production of ivangustin enantiomer analogues.

Qin XY, Chen BY, Fu JJ, Shan L, Lei XG, Zhang WD.

Eur J Med Chem. 2015 Sep 18;102:256-65. doi: 10.1016/j.ejmech.2015.07.051. Epub 2015 Aug 1.

PMID:
26280922
15.

New phenstatin-fatty acid conjugates: synthesis and evaluation.

Chen J, Brown DP, Wang YJ, Chen ZS.

Bioorg Med Chem Lett. 2013 Sep 15;23(18):5119-22. doi: 10.1016/j.bmcl.2013.07.025. Epub 2013 Jul 24.

PMID:
23932339
16.

Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.

Marminon C, Pierré A, Pfeiffer B, Pérez V, Léonce S, Joubert A, Bailly C, Renard P, Hickman J, Prudhomme M.

J Med Chem. 2003 Feb 13;46(4):609-22.

PMID:
12570382
17.

Synthesis of novel lipophilic N-substituted norcantharimide derivatives and evaluation of their anticancer activities.

Wu JY, Kuo CD, Chu CY, Chen MS, Lin JH, Chen YJ, Liao HF.

Molecules. 2014 May 26;19(6):6911-28. doi: 10.3390/molecules19066911.

18.

Design, synthesis and SAR analysis of antitumour styryl lactones related to (+)-crassalactones B and C.

Benedeković G, Popsavin M, Francuz J, Kovačević I, Kojić V, Bogdanović G, Divjaković V, Popsavin V.

Eur J Med Chem. 2014 Nov 24;87:237-47. doi: 10.1016/j.ejmech.2014.09.064. Epub 2014 Sep 22.

PMID:
25259516
19.

Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.

Stewart SG, Hill TA, Gilbert J, Ackland SP, Sakoff JA, McCluskey A.

Bioorg Med Chem. 2007 Dec 1;15(23):7301-10. Epub 2007 Aug 24.

PMID:
17870547
20.

Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition.

Fancelli D, Berta D, Bindi S, Cameron A, Cappella P, Carpinelli P, Catana C, Forte B, Giordano P, Giorgini ML, Mantegani S, Marsiglio A, Meroni M, Moll J, Pittalà V, Roletto F, Severino D, Soncini C, Storici P, Tonani R, Varasi M, Vulpetti A, Vianello P.

J Med Chem. 2005 Apr 21;48(8):3080-4.

PMID:
15828847

Supplemental Content

Support Center